![David Fuller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Fuller
Chief Tech/Sci/R&D Officer at
DIMERIX LIMITED
Profile
David Fuller is Chairman at EpiAxis Therapeutics Pty Ltd. since 2020.
Dr. Fuller is Chief Medical Officer at Dimerix Ltd. since 2023.
Former roles include Non-Executive Director at Linear Clinical Research Ltd., Non-Executive Director at AdAlta Ltd. from 2020 to 2026, and Chief Medical Officer at Racura Oncology Ltd. from 2021 to 2022.
Education includes an undergraduate degree from The University of Sydney.
David Fuller active positions
| Companies | Position | Start |
|---|---|---|
| DIMERIX LIMITED | Chief Tech/Sci/R&D Officer | 30/09/2023 |
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Chairman | 30/06/2020 |
Former positions of David Fuller
| Companies | Position | End |
|---|---|---|
| ADALTA LIMITED | Director/Board Member | 16/04/2026 |
| RACURA ONCOLOGY LTD | Chief Tech/Sci/R&D Officer | 10/11/2022 |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Director/Board Member | - |
Linear Clinical Research Ltd. | Director/Board Member | - |
Training of David Fuller
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dimerix Ltd.
 Dimerix Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of biopharmaceutical drugs | Health Technology |
AdAlta Ltd.
 AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
Linear Clinical Research Ltd. | |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Health Technology |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Health Technology |
- Stock Market
- Insiders
- David Fuller
